Pexidartinib Demonstrates Great Tumor Response in Tenosynovial Giant Cell Tumors by HMP Global

Niraparib After First-Line Chemotherapy New Standard of Care for Advanced Ovarian Cancer by HMP Global

Amer Zeidan, MBBS, MHS, Yale University, discusses diagnosis and treatment of Myelodysplastic Syndrome(MDS)at 2019 ASH Meeting on Hematologic Malignancies

Newer Treatment Options for Patients With Hodgkin Lymphoma by HMP Global

Treating Newly Diagnosed Patients With MCL by HMP Global

Matthew Seymour, MD, discusses the FOxTROT trial that supports preoperative chemotherapy as a treatment with multiple, clear benefits for patients with colon cancer.

Isatuximab Triplet Encouraging for Relapsed/Refractory Multiple Myeloma by HMP Global

Neratinib Plus Capecitabine Improves PFS in HER2-Positive Breast Cancer by HMP Global

Sara A. Hurvitz, MD, University of California-Los Angeles Jonsson Comprehensive Cancer Center, discusses the background, findings, and clinical significance of the MONALEESA 7 trial, the findings of which were presented at the 2019 ASCO Annual Meeting.

Ixazomib Promising Maintenance Therapy Option for Multiple Myeloma by HMP Global